Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study.
Hamaguchi M, Yoshimura Y, Nakajima H, Tanaka T, Hasegawa G, Ishii M, Okada H, Mitsuhashi K, Kitagawa N, Okamura T, Hashimoto Y, Majima S, Senmaru T, Ushigome E, Nakanishi N, Asano M, Yamazaki M, Fukui M; RISING-STAR study group.
Hamaguchi M, et al. Among authors: tanaka t.
J Clin Biochem Nutr. 2022 Sep;71(2):158-164. doi: 10.3164/jcbn.22-7. Epub 2022 May 17.
J Clin Biochem Nutr. 2022.
PMID: 36213793
Free PMC article.